Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm Metastasis × trastuzumab duocarmazine × 30 days × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 1 Pathologic Complete Response 1 Neoplasms 1 Hemangiosarcoma 1 Breast Neoplasms 1

Interventions

Specimen Handling 32 Biopsy 30 Magnetic Resonance Spectroscopy 21 pembrolizumab 16 Nivolumab 10 trastuzumab deruxtecan 9 Paclitaxel 9 Pemetrexed 8 Cisplatin 8 Carboplatin 8 Taxes 7 Leucovorin 6 Irinotecan 6 Gemcitabine 6 Fulvestrant 6 Fluorouracil 6 Capecitabine 6 130-nm albumin-bound paclitaxel 6 X-Rays 5 Radiosurgery 5 Oxaliplatin 5 Ipilimumab 5 Cetuximab 5 abemaciclib 4 Trastuzumab 4 Drug Therapy 4 Doxorubicin 4 Cyclophosphamide 4 tislelizumab 3 talazoparib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡